Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/10/2012 | CN1829482B Medicine box for treatment of dependence withdrawal |
10/10/2012 | CN1822817B Inhalable formulations for treating pulmonary hypertension and methods of using same |
10/10/2012 | CN1662251B Adjuvant enhanced immunotherapy |
10/10/2012 | CN102725303A 4 ' - azido - nucleosides as anti - HCV compunds |
10/10/2012 | CN102725302A 2'-fluoro-6'-methylene carbocyclic nucleosides and methods of treating viral infections |
10/10/2012 | CN102725298A Hydroxy-substituted cold(III) porphyrin complexes as histone deacetylase inhibitors |
10/10/2012 | CN102725297A Process for preparation of cephalosporin derivative |
10/10/2012 | CN102725294A Crystalline forms of (s)-1-(4-(5-cyclopropyl-1h-pyrazol-3- ylamino)pyrrolo [1,2-f] [1,2,4] triazin-2-yl)-n-(6-fluoropyridin- 3-yl)-2-methylpyrrolidine-2-carboxamide |
10/10/2012 | CN102725293A A polymorph form of nevirapine and its preparation |
10/10/2012 | CN102725292A Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition |
10/10/2012 | CN102725291A Bicyclic pyridines and analogs as sirtuin modulators |
10/10/2012 | CN102725290A Fused heterocyclic compounds as ion channel modulators |
10/10/2012 | CN102725288A Method for manufacturing a 6-substituted-1-methyl-1H-benzimidazole derivative, and manufacturing intermediate from said method |
10/10/2012 | CN102725287A 1,3,4-oxadiazole-2-carboxamide compound |
10/10/2012 | CN102725285A (3-fluoro-2-hydroxy)propyl-functionalized aryl derivatives or pharmaceutically acceptable salts thereof, method for preparing same, and pharmaceutical composition containing same as active ingredients for the diagnosis or treatment of neurodegenerati |
10/10/2012 | CN102725284A Compound suitable for the treatment of synucleopathies |
10/10/2012 | CN102725283A Compounds and compositions as protein kinase inhibitors |
10/10/2012 | CN102725281A Azole derivatives as WTN pathway inhibitors |
10/10/2012 | CN102725274A Antimicrobial compounds and methods of making and using the same |
10/10/2012 | CN102725264A Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient |
10/10/2012 | CN102725263A Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient |
10/10/2012 | CN102725261A Arachidonic acid analogs and methods for analgesic treatment using same |
10/10/2012 | CN102725024A Enhanced anti-microbial PDT |
10/10/2012 | CN102725003A Aldehydes for in vivo imaging of aldh in cancer stem cells |
10/10/2012 | CN102724985A Use of lipid conjugates in the treatment of diseases associated with vasculature |
10/10/2012 | CN102724984A Enterococcal cell wall components and antibacterial use thereof |
10/10/2012 | CN102724983A Use of aerosolized levofloxacin for treating cystic fibrosis |
10/10/2012 | CN102724982A Pemirolast for the treatment of systemic low grade inflammation |
10/10/2012 | CN102724981A Method for predicting therapeutic effect of chemotherapy on hepatocellular carcinoma patient |
10/10/2012 | CN102724980A Therapeutic use of protein-polymer conjugates |
10/10/2012 | CN102724979A Combination |
10/10/2012 | CN102724978A Use of ppar delta ligands for the treatment or prevention of inflammation or energy metabolism/production related diseases |
10/10/2012 | CN102724977A Fulvic acid in combination with fluconazole or amphotericin b for the treatment of fungal infections |
10/10/2012 | CN102724976A Metabolic imprinting effects of structured lipids |
10/10/2012 | CN102724975A IRE-1 a inhibitors |
10/10/2012 | CN102724974A Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist |
10/10/2012 | CN102724973A Methylsulfonylmethane (MSM) for treatment of drug resistant microorganisms |
10/10/2012 | CN102724972A Coated capsules and tablets of a fatty acid oil mixture |
10/10/2012 | CN102724971A Improved pharmacokinetics of S-adenosylmethionine formulations |
10/10/2012 | CN102724970A Tablet formulations of neratinib maleate |
10/10/2012 | CN102724965A Carboxyvinyl polymer-containing nanoparticle suspensions |
10/10/2012 | CN102724962A Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea |
10/10/2012 | CN102724961A Topical foam composition |
10/10/2012 | CN102724960A Topical foam composition |
10/10/2012 | CN102724884A Nutritional compositions comprising fruit flakes containing docosahexaenoic acid |
10/10/2012 | CN102724880A Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
10/10/2012 | CN102724878A Methods of providing weight loss therapy in patients with major depression |
10/10/2012 | CN102724877A Fatty acid niacin conjugates and their uses |
10/10/2012 | CN102724875A Pyrido[3,4-b]indoles and methods of use |
10/10/2012 | CN102721756A Synthesis of (R)-N-methylnaltrexone |
10/10/2012 | CN102719521A Application of cystine/glutamic acid reverse transporter xCT inhibitor in treating liver cancer |
10/10/2012 | CN102719397A Mesenchymal stem cell and application thereof in resisting HIV-1 (human immunodeficiency virus) |
10/10/2012 | CN102719368A Cell model for screening inhibitor of mycobacterium tuberculosis and screening method |
10/10/2012 | CN102718977A Heparin sodium-loaded polyurethane micro nanometer particle solution and preparation method and application thereof |
10/10/2012 | CN102718818A Nitrogenous troxerutin derivative, preparation method thereof and application |
10/10/2012 | CN102718817A Method for preparing anthocyanin extract from black bean peel |
10/10/2012 | CN102718816A 4''-O-(trans-beta-aryl allyl amide) formamyl azithromycin derivatives |
10/10/2012 | CN102718809A New diterpene compound in leaves of rubus corchorifolius L.f as well as preparation method and purpose thereof |
10/10/2012 | CN102718795A Dibutyltin coordination compound and preparation method and application thereof |
10/10/2012 | CN102718794A Dihydrazone Schiff base tindiphenyl (IV) coordinate complex and preparation method and application thereof |
10/10/2012 | CN102718793A Phenyltin coordination compound and preparation method and application thereof |
10/10/2012 | CN102718775A Macrocyclic quinazoline derivatives as antiproliferative agents |
10/10/2012 | CN102718772A Preparation and clinic application of hydroxycamptothecin derivative and preparation thereof |
10/10/2012 | CN102718769A Intermediary tetrasubstituted chlorin compound and application thereof in the field of medicines |
10/10/2012 | CN102718759A Heterocyclic CETP inhibitors |
10/10/2012 | CN102718758A Quinolinone derivative and application thereof as anti-schizophrenic drug |
10/10/2012 | CN102718757A 2H-1-benzopyran-2-one compounds with alpha-glucosidase inhibitory activity and medicinal composition of 2H-1-benzopyran-2-one compounds |
10/10/2012 | CN102718751A Pantoprazole salt crystal form and preparation method thereof |
10/10/2012 | CN102718750A Aminopyridine derivatives containing acridine ring and application thereof |
10/10/2012 | CN102718748A Compounds having analgesic and/or immunostimulant activity |
10/10/2012 | CN102718746A Trioxymethylene fumarate crystal form A and pharmaceutical usage thereof |
10/10/2012 | CN102718745A Novel amino pyridine compound, its preparation method, pharmaceutical composition containing compound and application thereof |
10/10/2012 | CN102718744A Compounds and methods for the treatment or prevention of flavivirus infections |
10/10/2012 | CN102718735A 2-ethyl-3-(4-hydroxy) benzoyl benzofuran compounds and compositions and preparation methods of compounds |
10/10/2012 | CN102718730A Methods of synthesis and/or purification of diaminophenothiazinium compounds |
10/10/2012 | CN102718727A Arylurea derivative with dual GK/PPAR agonist activities |
10/10/2012 | CN102718726A (z)-5-benzylidene thiazoline-4-thiazoline derivative as immunomodulator |
10/10/2012 | CN102718721A 4,4-disubstituted-dihydrogen-2(1H)-quinazolone or thioketone compound, synthetic method and application thereof |
10/10/2012 | CN102718710A Morphinan compounds |
10/10/2012 | CN102718708A Novel nitrogen-containing heteroaryl compounds and methods of use thereof |
10/10/2012 | CN102718703A Dimethyl-containing arylurea derivative with dual GK/PPAR agonist activities |
10/10/2012 | CN102718702A Aminopyridine derivatives and application thereof |
10/10/2012 | CN102718696A Preparation method and anti-AIDS purpose of Baculiferin L and analog thereof |
10/10/2012 | CN102718693A Carbazochrome sodium sulfonate compound and composition thereof |
10/10/2012 | CN102718676A Agomelatine sulfate and preparation method thereof |
10/10/2012 | CN102718675A Agomelatine methanesulfonic acid complex and preparation method thereof |
10/10/2012 | CN102718674A Myrcenyl amide as well as synthesis method and applications thereof |
10/10/2012 | CN102718658A Isosteviol derivative as well as preparation method and application thereof |
10/10/2012 | CN102718650A 2-(2- hydroxyl-5-(methoxycarbonyl) phenoxyl) benzoic acid as well as preparation method and application thereof |
10/10/2012 | CN102716498A Drug liposome capable of efficient and highly specific killing of P53 gene mutation type of breast cancer cells |
10/10/2012 | CN102716496A Clathrate compound of scutellarin and alkaline cyclodextrin and preparation method thereof |
10/10/2012 | CN102716494A Nucleic acid medicine loading system for targeted therapy and preparation method of nucleic acid medicine loading system |
10/10/2012 | CN102716493A Copolymer containing amorphous agomelatine, and preparation method, pharmaceutical composition and application thereof |
10/10/2012 | CN102716492A Baicalin hydroxypropyl-beta-cyclodextrin inclusion compound as well as preparation method and application thereof |
10/10/2012 | CN102716491A Clathrate compound of artemisinin series and alkaline cyclodextrin and method for preparing same |
10/10/2012 | CN102716490A Method for preparation of pharmaceutical composition having improved disintegradability |
10/10/2012 | CN102716488A Glycyrrhizic acid aureola dimer mediated targeted medication body as well as preparation method and purpose of glycyrrhizic acid aureola dimer mediated targeted medication body |
10/10/2012 | CN102716487A Permeation enhancer for improving transdermal absorption of Ginsenoside-Rd and application thereof |
10/10/2012 | CN102716486A Slowly-releasing anticancer drug composition and application thereof |
10/10/2012 | CN102716465A Pharmaceutical composite for treating tumor and preparation method of pharmaceutical composite |